Treatment planning meetings usually include a surgeon, a radiation oncologist, a medical or clinical oncologist, a physicist and a radiographer.

These resources include scientific meetings, educational conferences, professional workshops, and special symposia on issues of particular relevance and importance to clinical oncologists and researchers.

In the United Kingdom and several other countries, oncologists may be either clinical or medical oncologists.

The main difference is that clinical oncologists deliver radiotherapy, while medical oncologists do not.

The irreducible fact is that failure is the clinical oncologist's constant companion.

They work closely with clinical oncologists in planning treatment.

But now another study, to be presented on May 16 at the clinical oncologists' meeting, calls that assumption into question.

In some countries (not the United States), radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist".

In the United Kingdom, clinical oncologists, who practise radiotherapy are also fully qualified to administer chemotherapy.

Although clinical oncologists appeared to have hit a wall at this point in terms of results, progress was being made to understand the mechanisms underlying cancer.